Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project.

@article{Fricke1992HumanIV,
  title={Human immunodeficiency virus infection due to clotting factor concentrates: results of the Seroconversion Surveillance Project.},
  author={W A Fricke and L Augustyniak and David Lawrence and Alan Brownstein and Anneke Kramer and Bruce L. Evatt},
  journal={Transfusion},
  year={1992},
  volume={32 8},
  pages={707-9}
}
From 1987 to the present, the Seroconversion Surveillance Project has provided the means by which to monitor the risk of transmission of human immunodeficiency virus (HIV) by clotting factor concentrates. One hundred thirty-one hemophilia treatment centers in the United States are contacted regularly, and data on HIV testing of patients are collected. To date, 4366 (46.0%) of 9496 patients have been reported to be seropositive, and 37 new seroconversions have been identified. Nine of these have… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-2 of 2 extracted citations

Similar Papers

Loading similar papers…